TrialInvestigational new drugs2023

Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects.

Linlin Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.